These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1994180)

  • 1. Captopril attenuates reflex adrenergic response in essential hypertension.
    Mohara O; Masuyama Y
    Life Sci; 1991; 48(2):203-7. PubMed ID: 1994180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertension.
    Soto ME; Thibonnier M; Sire O; Menard J; Corvol P; Milliez P
    Eur J Clin Pharmacol; 1981; 20(3):157-61. PubMed ID: 7026255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Matsuura H; Shingu T; Kajiyama G
    Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II mediates hyperadrenergic activity evoked by sodium restriction in essential hypertension.
    Mohara O; Masuyama Y
    Life Sci; 1991; 49(13):939-45. PubMed ID: 1886454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the chronotropic property of captopril in hypertensive patients.
    Imai Y; Abe K; Sato M; Haruyama T; Hiwatari M; Goto T; Sato K; Kasai Y; Tajima J; Yoshinaga K
    Am Heart J; 1982 Dec; 104(6):1339-45. PubMed ID: 6128916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans.
    Miyajima E; Shigemasa T; Yamada Y; Tochikubo O; Ishii M
    Clin Exp Pharmacol Physiol; 1999 Oct; 26(10):797-802. PubMed ID: 10549404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion.
    Polonia JJ; Monteiro A; Esteves A; Cunha ME; Santos ML; Coutinho J; Coelho JL; Brandao FA; Cerqueira-Gomes M
    Am J Med; 1988 Mar; 84(3A):148-51. PubMed ID: 3064593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.
    Guazzi MD; De Cesare N; Galli C; Salvioni A; Tramontana C; Tamborini G; Bartorelli A
    Circulation; 1984 Aug; 70(2):279-84. PubMed ID: 6375889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma noradrenaline level after oral administration of captopril].
    Mohara O; Ueno Y; Nishio H; Nakamura Y; Masuyama Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):79-86. PubMed ID: 3553382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflex control of circulation and angiotensin converting enzyme inhibition in man.
    Mancia G; Giannattasio C; Grassi G; Morganti A; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(3):S45-9. PubMed ID: 3066877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurohumoral response to sublingual captopril and nifedipine in hypertensive emergencies and during the cold test. Contribution to the study of the interaction between the sympathetic and renin-angiotensin systems and atrial natriuretic factor].
    Polónia JJ; Pedro-Nunes J; da Silva MV; Esteves AP; Cunha ME; Brandão FA; Gomes MC
    Rev Port Cardiol; 1988; 7(4):389-98. PubMed ID: 2978843
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril and nifedipine in combination for moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    Hypertension; 1987 Jun; 9(6):629-33. PubMed ID: 3294594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.
    Morganti A; Grassi G; Sala C; Capozi A; Turolo L; Sabadini E; Bolla G; Mancia G; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S259-62. PubMed ID: 2856713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.
    Clementi WA; Durst NL; McNay JL; Keeton TK
    Hypertension; 1986 Mar; 8(3):229-37. PubMed ID: 3512428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of norepinephrine in the lack of reflex tachycardia after angiotensin converting enzyme inhibitor treatment.
    Yagi A; Ichikawa S; Sakamaki T; Ono Z; Sato K; Nakamura T; Murata K
    Tohoku J Exp Med; 1992 Apr; 166(4):429-37. PubMed ID: 1502689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.